Sen Yachi
YOU?
Author Swipe
View article: Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational Study
Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational Study Open
Objectives: The potential benefit of routine prophylactic anticoagulation for all hospitalized patients with clinically stable coronavirus disease 2019 (COVID-19) is still controversial. Method: The CLOT-COVID Study was a mul…
View article: Clinical Features Comparing Arterial Thrombosis and Venous Thromboembolism in Hospitalized Patients with COVID-19: Result from the CLOT-COVID Study
Clinical Features Comparing Arterial Thrombosis and Venous Thromboembolism in Hospitalized Patients with COVID-19: Result from the CLOT-COVID Study Open
Objectives: This study aimed to investigate the clinical features of arterial thrombosis and venous thromboembolism (VTE) in coronavirus disease 2019 (COVID-19). Methods: The CLOT-COVID Study was a retrospective, multicenter …
View article: Risk Factors and Impact on Outcomes of Thrombosis in Patients with COVID-19 in Japan: From the CLOT-COVID Study
Risk Factors and Impact on Outcomes of Thrombosis in Patients with COVID-19 in Japan: From the CLOT-COVID Study Open
Objectives: The relationship between the thrombotic event and prognosis in patients with coronavirus disease 2019 (COVID-19) has not yet been fully investigated in Japan. Our study aimed to investigate the clinical outcomes and risk…
View article: Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan
Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan Open
View article: Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID Study
Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID Study Open
This large-scale observational study in Japan identified several independent risk factors for mortality in hospitalized patients with COVID-19 that could facilitate appropriate risk stratification of patients with COVID-19.
View article: Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study Open
Background The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and a potential benefit of anticoagulation therapy has been documented for prevention of thromboembolic events. Bleeding events has also been reported as a no…
View article: Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID study
Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID study Open
View article: Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study Open
In the current large observational study of patients with COVID-19, the risk of mortality became markedly higher with increased age. However, the risks of thrombosis and major bleeding did not necessarily increase as age increases, which s…
View article: Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission ― From the CLOT-COVID Study ―
Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission ― From the CLOT-COVID Study ― Open
Approximately 20% of patients with moderate COVID-19 had worsened severity during hospitalization. Increased age, diabetes, D-dimer levels >1.0 μg/mL on admission, and the development of thrombosis during hospitalization were significantly…
View article: Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational Study
Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational Study Open
Among a cohort of critically ill patients with COVID-19, approximately half received therapeutic-dose anticoagulation, although it did not show a potential benefit compared with prophylactic-dose anticoagulation.
View article: Incidence, Risk Factors, and Clinical Impact of Major Bleeding in Hospitalized Patients with COVID-19: A Sub-analysis of the CLOT-COVID Study
Incidence, Risk Factors, and Clinical Impact of Major Bleeding in Hospitalized Patients with COVID-19: A Sub-analysis of the CLOT-COVID Study Open
Background: The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and a potential benefit of anticoagulation therapy has been documented for prevention of thromboembolic events. Bleeding events has also been reported as a n…
View article: The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study
The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study Open
View article: Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study Open
View article: D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan ― From the CLOT-COVID Study ―
D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan ― From the CLOT-COVID Study ― Open
Background: To date, there are no large-scale data on the association between D-dimer levels at admission and the occurrence of venous thromboembolism (VTE) in Japanese patients with coronavirus disease 2019 (COVID-19).
View article: The Association between the Development of Thrombosis and Worsening of Disease Severity in Patients with Moderate COVID-19 on Admission: From the CLOT-COVID Study
The Association between the Development of Thrombosis and Worsening of Disease Severity in Patients with Moderate COVID-19 on Admission: From the CLOT-COVID Study Open
View article: Influence of Sex on Development of Thrombosis in Patients with COVID-19: From the CLOT-COVID Study
Influence of Sex on Development of Thrombosis in Patients with COVID-19: From the CLOT-COVID Study Open
View article: Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the CLOT-COVID Study
Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the CLOT-COVID Study Open
View article: Relation between Success Placement of Central Venous Port and Left Brachiocephalic Vein Stenosis
Relation between Success Placement of Central Venous Port and Left Brachiocephalic Vein Stenosis Open
【目的】CVポート留置術の成否と左腕頭静脈狭窄との関連を調査した。【方法】対象149例の手技成否と術前CTでの腕頭静脈周辺の解剖学的な関連を調査した。【結果】左側アプローチ中9.5%がカテーテル不通過であった。カテーテル不通過群は通過群と比べ，胸骨大動脈間距離，左腕頭静脈の径および走行角度が有意に小さかった。【結論】狭小な胸骨大動脈距離，左腕頭静脈の狭窄および急峻な走行角度が，カテーテル通過困難の要因であると考えられた。